149 related articles for article (PubMed ID: 1812348)
1. Target-specific superparamagnetic MR contrast agents.
Weissleder R
Magn Reson Med; 1991 Dec; 22(2):209-12; discussion 213-5. PubMed ID: 1812348
[No Abstract] [Full Text] [Related]
2. How can superparamagnetic iron oxides be used to monitor disease and treatment?
Unger EC
Radiology; 2003 Dec; 229(3):615-6. PubMed ID: 14657295
[No Abstract] [Full Text] [Related]
3. Iron oxides as MR imaging contrast agents.
Fahlvik AK; Klaveness J; Stark DD
J Magn Reson Imaging; 1993; 3(1):187-94. PubMed ID: 8428086
[No Abstract] [Full Text] [Related]
4. [Focal nodular hyperplasia of the liver: imaging findings with emphasis on the findings of superparamagnetic iron oxide-enhanced MR imaging].
Han JK; Kim SH
Korean J Hepatol; 2006 Mar; 12(1):116-9. PubMed ID: 16565614
[No Abstract] [Full Text] [Related]
5. MR enhancement of hepatoma by superparamagnetic iron oxide (SPIO) particles.
Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Takahashi M
J Comput Assist Tomogr; 1995; 19(4):665-7. PubMed ID: 7622710
[No Abstract] [Full Text] [Related]
6. Superparamagnetic particles as an oral contrast agent in abdominal magnetic resonance imaging.
Oksendal AN; Jacobsen TF; Gundersen HG; Rinck PA; Rummeny E
Invest Radiol; 1991 Nov; 26 Suppl 1():S67-70; discussion S71. PubMed ID: 1808152
[No Abstract] [Full Text] [Related]
7. Basic physics of MR contrast agents and maximization of image contrast.
Hendrick RE; Haacke EM
J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
[TBL] [Abstract][Full Text] [Related]
8. Splenosis: superparamagnetic iron oxide-enhanced MR imaging.
Storm BL; Abbitt PL; Allen DA; Ros PR
AJR Am J Roentgenol; 1992 Aug; 159(2):333-5. PubMed ID: 1632350
[No Abstract] [Full Text] [Related]
9. The magnetic properties of some materials affecting MR images.
Josephson L; Bigler J; White D
Magn Reson Med; 1991 Dec; 22(2):204-8; discussion 213-5. PubMed ID: 1812347
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex).
Harisinghani MG; Saini S; Hahn PF; Weissleder R; Mueller PR
Acad Radiol; 1998 Apr; 5 Suppl 1():S167-9, discussion S183-4. PubMed ID: 9561072
[No Abstract] [Full Text] [Related]
11. Pitfalls in employing superparamagnetic iron oxide particles for stem cell labelling and in vivo MRI tracking.
Wang YX; Wang HH; Au DW; Zou BS; Teng LS
Br J Radiol; 2008 Dec; 81(972):987-8. PubMed ID: 19029055
[No Abstract] [Full Text] [Related]
12. Application of superparamagnetic iron oxide (AMI-227) for 3D phase-contrast MR angiography.
Tanimoto A; Yuasa Y; Hiramatsu K
Acad Radiol; 1998 Apr; 5 Suppl 1():S113-5. PubMed ID: 9561058
[No Abstract] [Full Text] [Related]
13. Magnetic resonance lymphography. Enhancement patterns using superparamagnetic nanoparticles.
Clément O; Guimaraes R; de Kerviler E; Frija G
Invest Radiol; 1994 Jun; 29 Suppl 2():S226-8. PubMed ID: 7928239
[No Abstract] [Full Text] [Related]
14. Ultrasmall superparamagnetic iron oxide-enhanced MR imaging of atherosclerotic plaque in hyperlipidemic rabbits.
Ruehm SG; Corot C; Vogt P; Cristina H; Debatin JF
Acad Radiol; 2002 May; 9 Suppl 1():S143-4. PubMed ID: 12019852
[No Abstract] [Full Text] [Related]
15. Frequency dependence of MR relaxation times. II. Iron oxides.
Bulte JW; Vymazal J; Brooks RA; Pierpaoli C; Frank JA
J Magn Reson Imaging; 1993; 3(4):641-8. PubMed ID: 8347958
[TBL] [Abstract][Full Text] [Related]
16. Functional and anatomic imaging of tumor vasculature: high-resolution MR spectroscopic imaging combined with a superparamagnetic contrast agent.
Karczmar GS; Fan X; Al-Hallaq H; River JN; Tarlo K; Kellar KE; Zamora M; Rinker-Schaeffer C; Lipton MJ
Acad Radiol; 2002 May; 9 Suppl 1():S115-8. PubMed ID: 12019844
[No Abstract] [Full Text] [Related]
17. MR lymphography: evidence of extravasation of superparamagnetic nanoparticles into the lymph.
Clement O; Rety F; Cuenod CA; Siauve N; Carnot F; Bordat C; Siche M; Frija G
Acad Radiol; 1998 Apr; 5 Suppl 1():S170-2; discussion S183-4. PubMed ID: 9561073
[No Abstract] [Full Text] [Related]
18. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents.
Frank JA; Zywicke H; Jordan EK; Mitchell J; Lewis BK; Miller B; Bryant LH; Bulte JW
Acad Radiol; 2002 Aug; 9 Suppl 2():S484-7. PubMed ID: 12188316
[No Abstract] [Full Text] [Related]
19. Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review.
Petersein J; Saini S; Weissleder R
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):53-60. PubMed ID: 8673716
[TBL] [Abstract][Full Text] [Related]
20. Vascular enhancement with superparamagnetic iron oxide.
Van Gansbeke D; Matos C; Metens T
AJR Am J Roentgenol; 1996 Sep; 167(3):813-4. PubMed ID: 8751704
[No Abstract] [Full Text] [Related]
[Next] [New Search]
